Company

Cannara Biotech, Inc.

Headquarters: Montreal, QC, Canada

CEO: Mr. Zohar Krivorot

TSXV: LOVE +0.53%

Market Cap

C$141.7 Million

CAD as of July 1, 2025

US$103.9 Million

Market Cap History

Cannara Biotech, Inc. Categories

Canada Healthcare Drug Manufacturers—Specialty & Generic
Canada Healthcare Canada Drug Manufacturers—Specialty & Generic

Cannara Biotech, Inc. market capitalization over time

Evolution of Cannara Biotech, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Cannara Biotech, Inc.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $70.87 B
MERCK Kommanditgesellschaft auf Aktien $55.96 B
Takeda Pharmaceutical Company Limited $48.34 B
Haleon plc $46.46 B
Hansoh Pharmaceutical Group Company Ltd $23.59 B
Sector:
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Detailed Description

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-infused products in Canada. It also offers hemp-based CBD products through e-commerce platform. The company was incorporated in 2017 and is headquartered in Montreal, Canada.

Stocks & Indices

Cannara Biotech, Inc. has the following listings and related stock indices.


Stock: TSXV: LOVE wb_incandescent

Stock: FSX: 8CB wb_incandescent

Stock: OTC: LOVFF wb_incandescent

Details

Headquarters:

333 Decarie boulevard

Suite 200 St-Laurent

Montreal, QC H4N 3M9

Canada